A citrus-peel fiber processed small enough to enter the bloodstream, where it is proposed to quiet a protein that rises with age and drives scarring, inflammation, and cancer spread. Low-risk and food-derived, its main drawback is digestive discomfort. The strongest human signal is slowing a prostate cancer marker after relapse; broader benefits remain unproven. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Galectin-3 (serum) | < 14.0 ng/mL (lower is better) | Primary target and main way to judge whether MCP is doing anything measurable |
| High-sensitivity CRP | < 1.0 mg/L | General marker of body-wide inflammation the galectin-3 rationale predicts might improve |
| Comprehensive metabolic panel (CMP) | Standard reference range; eGFR > 90 mL/min/1.73m² | Tracks kidney and liver status relevant to fibrosis claims and to metal clearance |
| Serum iron, ferritin, and zinc | Iron 50–100 µg/dL; ferritin 50–150 ng/mL; zinc 90–130 µg/dL | Detects mineral depletion from long-term fiber binding or concurrent chelation |
| PSA (prostate-specific antigen; men only, if relevant) | < 4.0 ng/mL, with attention to the doubling-time trend | The one endpoint with direct human MCP data in relapsed prostate cancer |
| Heavy metals (blood/urine, if detox is the goal) | As low as reasonably achievable | Establishes body burden before and excretion during a detoxification protocol |
Cadence: Baseline before starting, then recheck at ~3 months to detect an early trend, then every 6–12 months during continued use; prostate-specific tracking every 3–6 months where applicable.